Organization
Kaiser Permanente Southern California
9 abstracts
Abstract
Evaluation of potential socioeconomic and racial/ethnic disparities in all-cause mortality in adolescent and young adult patients with cancer.Org: Kaiser Permanente School of Medicine, Kaiser Permanente Northern California, Kaiser Permanente Bernard J. Tyson School of Medicine, Kaiser Permanente Southern California,
Abstract
Menopausal hormone therapy and ovarian and endometrial cancers: Long-term follow-up of the Women’s Health Initiative randomized trials.Org: The Lundquist Research Institute, Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, Fred Hutchinson Cancer Research Center, Kaiser Permanente Southern California, Albert Einstein College of Medicine,
Abstract
The impact of HIV and CD4 count stratification on all cause mortality for adenocarcinoma and squamous cell lung cancers in the antiretroviral therapy era: Analysis of National Veterans Affairs and Kaiser Permanente Northern cohorts.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The University of Texas Health Science Center at Houston, MD Anderson Cancer Center, Baylor College of Medicine, Baylor College of Medicine Division of Diabetes Endocrinology and Metabolism,
Abstract
Charlson’s comorbidity and remission outcomes in women diagnosed with epithelial ovarian cancer.Org: Department of Research and Evaluation, Kaiser Permanente Southern California, Kaiser Permanente Southern California, MedHealth, Inc, Merck & Co., Inc.,
Abstract
Enfortumab vedotin (EV) with or without pembrolizumab (P) in patients (pts) who are cisplatin-ineligible with previously untreated locally advanced or metastatic urothelial cancer (la/mUC): Additional 3-month follow-up on cohort K data.Org: University of California, San Francisco Medical Center, University of North Carolina, Lineberger Comprehensive Cancer Center, University of Chicago, Yale Cancer Center, Yale School of Medicine, New Haven, CT, Duke Cancer Institute,
Abstract
Impact of next generation sequencing on a clinicians’ first line treatment decision in patients with stage IV non-small cell lung cancer.Org: Kaiser Permanente SCPMG, Kaiser Permanente School of Medicine, Kaiser Permanente Oakland Medical Center, Kaiser Permanente Southern California,
Abstract
Updated efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic NTRK fusion-positive (fp) non-small cell lung cancer (NSCLC).Org: Yonsei University College of Medicine, Seoul, Korea, Republic of (South), Taipei Medical University Hospital, Taipei City, Taiwan, City of Hope Comprehensive Cancer Center,
Abstract
Clinical remission rates in patients with epithelial ovarian cancer in the pandemic versus the pre-pandemic period.Org: Adventist Health White Memorial, Kaiser Permanente Oakland Medical Center, Kaiser Permanente Southern California, Department of Research and Evaluation, Kaiser Permanente Southern California, Merck & Co., Inc.,
Abstract
Adverse health effects of opioids in survivors of breast cancer after active cancer treatment.Org: Kaiser Permanente Southern California, Kaiser Permanente Oakland Medical Center, Kaiser Permanente Research, Alive and Well Women, The Lundquist Research Institute,